Pauline W Worters1, Dirk Beque2, Robert D Peters3, Dominic Graziani4, Michael Carl5, Graeme C McKinnon3, and Christopher J Hardy4
1GE Healthcare, Menlo Park, CA, United States, 2GE Global Research, Munich, Germany, 3GE Healthcare, Waukesha, WI, United States, 4GE Global Research, Niskayuna, NY, United States, 5GE Healthcare, San Diego, CA, United States
Synopsis
A silent 3D multi-echo gradient-echo pulse
sequence is developed for quantitative susceptibility mapping (QSM). The new,
silent sequence is compared to the standard acquisition and gives comparable susceptibility
values. The silent acquisition gives the benefit of patient comfort and
workflow ease at some cost to SNR and acquisition time.Purpose
Acoustic noise in MRI originates from rapid switching of magnetic
field gradients, which causes strong Lorentz forces that make the gradient
coils vibrate. While mechanical countermeasures such as acoustic damping
materials and improved hardware design have been used to help reduce sound
levels, the use of earplugs or headsets is still typically required to protect
hearing. Even with these measures, gradient noise can remain a source of
discomfort and impaired communication between subject and operator during scanning.
Other approaches to noise reduction have focused on the pulse sequence, e.g. [1];
one method previously applied to fast-spin-echo and gradient-echo pulse
sequences [2], is to minimize the harmonic content of the gradient waveforms through
the use of sinusoids. Here we demonstrate the effectiveness of this method in a
new silent T2*-weighted multi-echo 3D-gradient-echo sequence (SWAN, GE
Healthcare) for quantitative susceptibility mapping (QSM).
Methods
The acoustic response of whole-body MRI systems is typically
negligible below ~200Hz, and so, if the frequency content of the pulse sequence
is kept within this range, sound levels from the scan can be substantially
reduced. To achieve this, all but the weak
excitation slab-select trapezoidal gradients were replaced with sinusoids, to minimize
harmonic content. In order to compensate for the resulting non-uniform k-space
sampling, the readout resolution was oversampled; the sampling bandwidth was
accordingly increased such that the total duration of the readout was unchanged.
The commonly used Kaiser-Bessel kernel was used in the gridding algorithm.
A 3.0T MRI clinical system (Discovery MR750, GE Healthcare)
was used for all experiments. In a
standard head phantom, the fraction of the sine lobe sampled was investigated. The sound pressure level (SPL) was recorded
while varying the sine lobe fraction, at three different fields of view (FOV).
The SPL was measured using a Bruel & Kjaer 2250 sound-level meter with
microphone placed on the patient table ~1m from the end of the bore.
Three healthy subjects were scanned with the following two
protocols detailed in the table (Figure 1): (A) standard SWAN and (B) silent SWAN.
Silent SWAN was optimized to match the average TE (~20ms) of the standard
acquisition. Due to the increased echo
spacing (in order to maintain low frequency content of the pulse sequence),
effective flow signal preservation was difficult to achieve in some blood
vessels with first-order flow compensation (due to higher order motion). Thus,
flow compensation was not used for silent SWAN.
The output DICOM data were processed using the MEDI software
(Medimagemetric LLC [3,4]) for QSM maps. The maps were qualitatively compared
and the difference within the caudate nucleus was computed from a region of
interest (ROI).
Results
Figure 2 demonstrates phantom results while varying the
fraction of the sine lobe that is sampled. As the readout oversampling meets
the Nyquist criterion, no significant artifact is seen for all fractions. As
expected, the SPL increases with the fraction of sine-lobe sampled; an
increased fraction results in decreased echo spacing, with all other parameters
kept the same, and thus increased frequency content in the pulse sequence.
For the volunteer experiments, ambient SPL was 62±1 dBA. For
the standard SWAN protocol (Figure 1), SPL was 104 dBA, and for the silent protocol
was 73 dBA. (For lower-resolution protocols, levels were lower still, e.g., 67
dBA for 416×256×64, FOV 24x19.2 cm, with 0.5 sine-lobe fraction).
QSM images from a representative subject are shown in Figure
3. The maps from silent SWAN appear slightly noisier. The mean of the
susceptibility values in the caudate nucleus from standard and silent
acquisitions were 49.4±8.6 parts per
billion (ppb) and 49.4±15.5 ppb, and the mean paired difference was 0.1±24.1. Some
larger differences were observed at the periphery and blood vessels and could
be due to a combination of spatial misregistration (since no computational
registration was used) and lack of flow compensation in silent SWAN.
Discussion and Conclusion
We have demonstrated the application of sinusoidal gradients
to a multi-echo gradient-echo sequence for silent QSM. The silent acquisition costs some SNR and
acquisition time for the benefit of patient comfort and workflow ease. The quantitation is largely unaffected apart
from the increased noise, likely due to the fewer number of echoes in the
silent acquisition. The relatively weak signal
in areas of flow for the silent acquisition may have contributed to some
difference in susceptibility values between standard and silent acquisitions in
those locations. The actual SPL is dependent on many parameters, including the
fundamental gradient period and strength, and has a trade-off on the
acquisition efficiency (i.e., echo spacing and number of echoes).
Acknowledgements
No acknowledgement found.References
[1] Weiger M et al. ZTE imaging in humans. MRM 2013;70:328-32.
[2] Hennel
F. Fast spin echo and fast gradient echo MRI with low acoustic noise. JMRI
2001;13:960–6.
[3] Liu
J et al. Morphology enabled dipole inversion for quantitative susceptibility
mapping using structural consistency between the magnitude image and the
susceptibility map. Neuroimage 2012;59:2560–8.
[4] Liu
T et al. Nonlinear formulation of the magnetic field to source relationship for
robust quantitative susceptibility mapping. MRM 2013;69:467–76.